Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Acrocyte Therapeutics

Clinically adaptable platform that can generate single cell derived organoids with unprecedented speed
2021
Nov-50
11-50
Taipei, T’ai-pei, Taiwan
  • Bioanalytical Devices
  • Drug Discovery and Development
  • Pathology & Diagnostics
  • Personalized Medicine Technologies

Innovation

R&D Focus

Patient-derived 3D disease models for therapy selection

Innovative Solution

Clinically adaptable platform that can generate single cell derived organoids with unprecedented speed

Investment Funding

Last Funding Stage

Venture - Series Unknown

Last Funding Date

01-02-2023

Lead Investors

Darwin Venture Management

People

Founders

About

Clinically adaptable platform that can generate single cell derived organoids with unprecedented speed

Something missing or incorrect on this page? Help us enrich this information